Matt Abernethy, Chief Financial Officer of Neurocrine Biosciences Inc. (NASDAQ:NBIX), a company currently valued at $11.4 billion with strong financial health according to InvestingPro analysis, ...
Onyia Jude, Chief Scientific Officer at Neurocrine Biosciences Inc. (NASDAQ:NBIX), recently executed stock transactions involving the company's common shares. According to a recent SEC filing, Jude ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback